V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196229 | 20073181 | 1.54 | 80 | null | 2017-12-12 | 2017-12-12 | Sorafenib | 99 | null | SORAFENIB | 101114312 |
| 20196233 | 20073182 | 1.44 | 43.6 | Curative (C) | 2019-05-30 | 2019-06-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN | 100513282 |
| 20196235 | 20073183 | 0 | 0 | Palliative (P) | 2017-02-16 | 2017-02-16 | Sorafenib | 99 | null | SORAFENIB | 101590457 |
| 20196239 | 20073184 | 1.8 | 109.5 | Curative (C) | 2016-12-15 | 2017-01-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | FLUOROURACIL + MITOMYCIN | 100206196 |
| 20196241 | 20073185 | 1.7 | 105 | null | null | 2019-10-11 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101457692 |
| 20196242 | 20073186 | null | 90.3 | Palliative (P) | 2021-01-09 | 2021-01-09 | Sorafenib | 02 | N | SORAFENIB | 100988606 |
| 20196249 | 20073187 | 1.65 | 93 | null | 2019-12-27 | 2019-12-31 | Sorafenib | 02 | null | SORAFENIB | 100271106 |
| 20196250 | 20073188 | 1.67 | 63 | Neo-adjuvant (N) | 2019-05-24 | 2019-06-07 | Carboplatin + Paclitaxel (3 weekly) | N | Y | CARBOPLATIN + PACLITAXEL | 101120491 |
| 20196254 | 20073189 | 1.69 | 66.6 | Palliative (P) | 2017-04-19 | 2017-05-13 | Sorafenib | 02 | N | SORAFENIB | 101346096 |
| 20196255 | 20073190 | 1.55 | 68 | null | 2017-08-14 | 2017-08-30 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 100508842 |
| 20196256 | 20073191 | 1.62 | 51.6 | Neo-adjuvant (N) | 2018-04-12 | 2018-04-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100558802 |
| 20196264 | 20073192 | 1.82 | 57.4 | null | null | 2016-12-09 | FLUOROURACIL + MITOMYCIN + RT | 01 | null | FLUOROURACIL + MITOMYCIN | 100057688 |
| 20196266 | 20073193 | 0 | 0 | null | 2017-10-05 | 2017-10-23 | Sorafenib | 02 | Y | SORAFENIB | 101131842 |
| 20196268 | 20073194 | 1.85 | 81.8 | Curative (C) | 2017-08-02 | 2017-08-30 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100992481 |
| 20196270 | 20073195 | 1.75 | 80 | Curative (C) | 2017-03-18 | 2017-04-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 101203033 |
| 20196271 | 20073196 | 1.72 | 59.3 | Neo-adjuvant (N) | 2018-12-16 | 2018-12-22 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100317694 |
| 20196272 | 20073197 | 1.68 | 85 | Palliative (P) | 2017-05-10 | 2017-05-16 | Sorafenib | 02 | N | SORAFENIB | 100093034 |
| 20196277 | 20073198 | 1.63 | null | Curative (C) | 2017-08-15 | 2017-08-15 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 100401513 |
| 20196282 | 20073199 | 1.79 | 71.4 | Neo-adjuvant (N) | 2017-08-13 | 2017-08-15 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101108412 |
| 20196283 | 20073200 | 1.67 | 95.8 | Curative (C) | 2017-06-22 | 2017-06-23 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 101430577 |
| 20196289 | 20073201 | 1.82 | 89 | Curative (C) | 2017-05-12 | 2017-06-08 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN | 100826138 |
| 20196290 | 20073202 | 1.7 | 77.7 | Curative (C) | 2019-01-11 | 2019-01-20 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL | 101086706 |
| 20196292 | 20073203 | 1.64 | 92.1 | Palliative (P) | 2018-04-14 | 2018-04-28 | Sorafenib | 02 | N | SORAFENIB | 101012830 |
| 20196293 | 20073204 | 0 | 53.9 | Palliative (P) | 2017-04-09 | 2017-04-16 | Sorafenib | 02 | N | SORAFENIB | 100115039 |
| 20196294 | 20073205 | 1.61 | 54.8 | Curative (C) | 2018-05-19 | 2018-06-08 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN | 101387817 |
| 20196295 | 20073206 | null | 71.5 | Curative (C) | 2017-04-29 | 2017-05-04 | Sorafenib | 2 | Y | SORAFENIB | 100543209 |
| 20196296 | 20073207 | 1.64 | 69 | Curative (C) | 2016-03-07 | 2016-04-06 | FLUOROURACIL + MITOMYCIN | 02 | Y | FLUOROURACIL + MITOMYCIN | 101529178 |
| 20196299 | 20073208 | null | null | null | 2016-09-12 | 2016-09-26 | Sorafenib | 02 | Y | SORAFENIB | 101303108 |
| 20196300 | 20073209 | 1.81 | 0 | Neo-adjuvant (N) | 2016-06-03 | 2016-06-10 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100623030 |
| 20196301 | 20073210 | 1.69 | 79 | Palliative (P) | 2017-11-02 | 2017-11-14 | Sorafenib | 02 | Y | SORAFENIB | 100430564 |
| 20196305 | 20073211 | 1.83 | 58.6 | Palliative (P) | 2018-04-22 | 2018-04-30 | Sorafenib | 02 | N | SORAFENIB | 101040167 |
| 20196307 | 20073212 | 1.55 | 62 | Curative (C) | 2016-09-08 | 2016-09-08 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 101700200 |
| 20196308 | 20073213 | 1.58 | 93 | Palliative (P) | 2016-11-21 | 2016-11-21 | Sorafenib | 02 | N | SORAFENIB | 101223787 |
| 20196309 | 20073214 | null | null | Curative (C) | 2016-05-11 | 2016-05-11 | Carboplatin + Paclitaxel (weekly) | 99 | Y | SORAFENIB | 100645619 |
| 20196310 | 20073215 | 1.69 | 73.5 | Palliative (P) | 2017-07-27 | 2017-07-29 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101566813 |
| 20196317 | 20073216 | 1.75 | 62.4 | Curative (C) | 2020-02-17 | 2020-02-17 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 100399079 |
| 20196318 | 20073217 | 1.69 | 67.3 | Palliative (P) | 2016-11-10 | 2016-11-18 | Sorafenib | 02 | N | SORAFENIB | 101653881 |
| 20196319 | 20073218 | 1.59 | 47 | Neo-adjuvant (N) | 2019-06-07 | 2019-06-21 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100604560 |
| 20196321 | 20073219 | 0 | 111 | null | 2018-12-07 | 2018-12-09 | Sorafenib | 02 | Y | SORAFENIB | 101082424 |
| 20196323 | 20073220 | 1.75 | 57 | null | 2017-04-04 | 2017-04-25 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101265576 |
| 20196325 | 20073221 | null | 48.6 | Palliative (P) | 2020-07-19 | 2020-07-19 | Sorafenib | 02 | N | SORAFENIB | 101645528 |
| 20196326 | 20073222 | 1.82 | 92.9 | Curative (C) | 2018-07-19 | 2018-07-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100744256 |
| 20196329 | 20073223 | null | null | null | 2016-04-21 | 2016-05-05 | Sorafenib | 02 | Y | SORAFENIB | 100155574 |
| 20196332 | 20073224 | 1.68 | 82 | null | 2019-09-30 | 2019-10-28 | Sorafenib | 02 | Y | SORAFENIB | 100111121 |
| 20196335 | 20073225 | 1.7 | 68.7 | Curative (C) | 2018-12-07 | 2018-12-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100013456 |
| 20196337 | 20073226 | 1.78 | 80.6 | null | 2018-02-19 | 2018-02-19 | Sorafenib | 02 | Y | SORAFENIB | 101097552 |
| 20196342 | 20073227 | 1.87 | 54.8 | Palliative (P) | 2017-07-14 | 2017-07-24 | Sorafenib | 2 | N | SORAFENIB | 101790333 |
| 20196343 | 20073228 | 1.85 | 75.1 | Adjuvant (A) | 2020-01-08 | 2020-01-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100135053 |
| 20196344 | 20073229 | 1.7 | 112 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-12 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100357043 |
| 20196346 | 20073230 | 1.59 | 51 | Curative (C) | null | 2019-04-04 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 100736934 |